Coegin Pharma AB engages in biotechnology research and experimental development. Its nanotechnology is designed to manage inflammatory diseases and cancer. The firm also offers consultancy and management services. The company was founded in 2005 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company